Salisilat Zehirlenmeleri
Synopsis
Salisilatlar; analjezik, antipiretik, antienflamatuar ve antiplatelet etkileri nedeniyle yaygın şekilde kullanılan, fakat aşırı alımında öldürücü potansiyele sahip önemli bir ilaç grubudur. Asetilsalisilik asit (aspirin), salisilik asit ve metil salisilat gibi farklı formları bulunan salisilatlar hem oral hem de topikal yolla vücuda alınabilir. Terapötik dozlarda yarılanma ömrü 2 ila 4 saat arasında değişirken, yüksek dozlarda eliminasyon yolaklarının doyması nedeniyle bu süre 20 saate kadar uzayabilir. Zehirlenmeler gençlerde genellikle tek seferde yüksek doz alımıyla akut, yaşlı popülasyonda ise uzun süreli kullanım ve böbrek fonksiyon bozukluğu gibi nedenlerle kronik biçimde ortaya çıkar. Toksisitenin erken evresinde kulak çınlaması, baş dönmesi, bulantı ve kusma görülürken; ileri vakalarda bilinç değişikliği, nöbet, serebral ödem, non-kardiyak pulmoner ödem, koma ve ölüm gelişebilir. Patofizyolojik olarak salisilatlar solunum merkezini uyararak erken dönemde solunumsal alkaloza, ardından oksidatif fosforilasyonun bozulması ve keton birikimiyle artmış anyon açıklı metabolik asidoza neden olur. Tanı ayrıntılı anamnez, klinik bulgular, serum salisilat düzeyleri, serum pH'ı ve böbrek fonksiyonlarının takibi ile konulur. Spesifik bir antidotu olmayan salisilat zehirlenmesinde tedavi; havayolu ve dolaşım stabilizasyonu, aktif kömür ile gastrik dekontaminasyon, sodyum bikarbonat infüzyonu ile idrar alkalinizasyonu ve ağır tablolarda hemodiyaliz uygulanmasından oluşur.
Salicylates are a widely used group of medications due to their analgesic, antipyretic, anti-inflammatory, and anti-platelet effects, but they possess potentially lethal toxicity in overdose. Available in various forms including acetylsalicylic acid (aspirin), salicylic acid, and methyl salicylate, salicylates can be ingested orally or absorbed topically. While their half-life ranges from 2 to 4 hours at therapeutic doses, saturation of elimination pathways at high doses can extend this duration up to 20 hours. Poisoning typically manifests as acute toxicity from a single high-dose ingestion in younger patients, or as chronic toxicity due to prolonged usage and renal impairment in elderly populations. Early stages of toxicity present with tinnitus, dizziness, nausea, and vomiting, whereas severe cases can progress to altered mental status, seizures, cerebral edema, non-cardiogenic pulmonary edema, coma, and death. Pathophysiologically, salicylates stimulate the respiratory center causing early respiratory alkalosis, followed by uncoupling of oxidative phosphorylation and ketone accumulation resulting in high anion gap metabolic acidosis. Diagnosis relies on detailed clinical history, physical findings, serial serum salicylate levels, serum pH monitoring, and renal function assessments. Since no specific antidote exists, management includes airway and circulatory stabilization, gastric decontamination with activated charcoal, urinary alkalinization using sodium bicarbonate infusion, and hemodialysis in severe cases.
References
Flomenbaum NE.(2010) Chapter 35 Salicylates in Goldfrank’s Toxicologic Emergencies(9th Edition.,pp.508-519.) Mcgraw-hill. ISBN 0071605932, 9780071605939.
Pearlman BL, Gambhir R. Salicylate intoxication: a clinical review. Postgrad Med. 2009;121(4):162-8. doi: 10.3810/pgm.2009.07.2041.
Palmer BF, Clegg DJ. Salicylate Toxicity. N Engl J Med. 2020;382(26):2544-2555. doi:10.1056/NEJMra2010852. PMID: 32579814.
Davison C. Salicylate metabolism in man. Ann N Y Acad Sci. 1971;179:249-68. doi: 10.1111/j.1749-6632.1971.tb46905.x.
Hogben CAM, Schanker LS, Jocco DJ, et al. Absorption of drugs from the stomach. II: the human. J Pharmacol Exp Ther. 1957;120:540-545.
Burke A, Smyth E, FitzGerald GA.(2006). Analgesic-antipyretic agents; pharmacotherapy of gout. In: Brunton LL, Lazo JS, Parker KL, (eds). Goodman & Gilman’s The Pharmacological Basis of Therapeutics ,(11th ed.,pp.671-715) New York: McGraw-Hill.
Levy G. Clinical pharmacokinetics of aspirin. Pediatrics 1978; 62: Suppl: 867-72.
Yü TF, Gutman AB. Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Invest 1959; 38: 1298-315.
Pillinger MH, Capodici C, Rosenthal P, et al. Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion. Proc Natl Acad Sci U S A 1998; 95:14540.
Dargan PI, Wallace CI, Jones AL. An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose. Emerg Med J 2002; 19: 206-9.
Levy G. Pharmacokinetics of salicylate elimination in man. J Pharm Sci 1965; 54: 959-67.
Hill JB. Salicylate intoxication. N Engl J Med 1973; 288:1110.
Thisted B, Krantz T, Strøom J, et al. Acute salicylate self-poisoning in 177 consecutive patients treated in ICU. Acta Anaesthesiol Scand 1987; 31:312.
Rauschka H, Aboul-Enein F, Bauer J, et al. Acute cerebral white matter damage in lethal salicylate intoxication. Neurotoxicology 2007; 28:33.
Miyahara JT, Karler R. Effect of salicylate on oxidative phosphorylation and respiration of mitochondrial fragments. Biochem J . 1965;97:194-198.
Thurston JH, Pollock PG, Warren SK, et al. Reduced brain glucose with normal plasma glucose in salicylate poisoning. J Clin Invest 1970; 49:2139.
Liu P, Qin D, Huang X, et al. Neurotoxicity of sodium salicylate to the spiral ganglion neurons: GABAA receptor regulates NMDA receptor by Fyn-dependent phosphorylation. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2019;205(4):469-479. doi: 10.1007/s00359-019-01339-z.
Glisson JK, Vesa TS, Bowling MR. Current management of salicylate-induced pulmonary edema. South Med J. 2011;104(3):225-32. doi: 10.1097/SMJ.0b013e318205e548.
Walters JS, Woodring JH, Stelling CB, et al. Salicylate-induced pulmonary edema. Radiology 1983; 146:289.
Yuklyaeva N, Chaudhary A, Gorantla R,et al. Salicylate-induced pulmonary edema--a near-miss diagnosis. Am J Emerg Med. 2014;32(5):490.e5-6. doi: 10.1016/j.ajem.2013.11.021.
Scarpignato C. Nonsteroidal anti-infl ammatory drugs: how do they damage gastroduodenal mucosa? Dig Dis. 1995;13(suppl 1):9–39.
D’Agati V. Does aspirin cause acute or chronic renal failure in experimental animals and in humans? Am J Kidney Dis. 1996;28(1 suppl 1):24-29.
Wortzman DJ, Grunfeld A. Delayed absorption following enteric-coated aspirin overdose. Ann Emerg Med 1987;16:434-436.
Rivera W, Kleinschmidt KC, Velez LI, et al. Delayed salicylate toxicity at 35 hours without early manifestations following a single salicylate ingestion. Ann Pharmacother 2004; 38:1186.
Juurlink DN, Gosselin S, Kielstein JT, et al. Extracorporeal Treatment for Salicylate Poisoning: Systematic Review and Recommendations From the EXTRIP Workgroup. Ann Emerg Med 2015; 66:165.
Alvan G, Bergman V, Gustafsson L. High unbound fraction of salicylate in plasma during intoxication. Br J Clin Pharmacol. 1981;11:625-626.
Boyer EW, Weibrecht KW. Salicylate (aspirin) poisoning in adults. In: UpToDate, Traub SJ (Ed), UpToDate, Waltham, MA. (Accessed on January 04, 2021.).
Proudfoot AT. Toxicity of salicylates. Am J Med. 1983;14:75(5A): 99–103.
Greenberg MI, Hendrickson RG, Hofman M. Deleterious effects of endotracheal intubation in salicylate poisoning. Ann Emerg Med 2003; 41: 583-584.
Proudfoot AT, Krenzelok EP, Vale JA. Position Paper on urine alkalinization. J Toxicol Clin Toxicol 2004; 42: 1-26.
Sweeney KR, Chapron DJ, Brandt JL et al. Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation. Clin Pharmacol Ther 1986; 40: 518-524.
Gumz ML, Lynch IJ, Greenlee MM et al. The renal H+-K+-ATPases: physiology, regulation, and structure. Am J Physiol Renal Physiol. 2010;298(1):F12-21. doi: 10.1152/ajprenal.90723.2008.
King JD, Kern MH, Jaar BG. Extracorporeal Removal of Poisons and Toxins. Clin J Am Soc Nephrol. 2019;14(9):1408-1415. doi: 10.2215/CJN.02560319.
Juurlink DN, Gosselin S, Kielstein JT, et al. Extracorporeal Treatment for Salicylate Poisoning: Systematic Review and Recommendations From the EXTRIP Workgroup. Ann Emerg Med 2015; 66:165.
Higgins RM, Connolly JO, Hendry BM. Alkalinization and hemodialysis in severe salicylate poisoning: comparison of elimination techniques in the same patient. Clin Nephrol. 1998;50(3):178–183.